References
- JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin201161699021296855
- ZhengYWuCXWuF[Status and trends of breast cancer mortality in Chinese females.]Zhonghua Yu Fang Yi Xue Za Zhi201145150154 Chinese21426796
- BlythKCameronERNeilJCThe RUNX genes: gain or loss of function in cancerNat Rev Cancer2005537638715864279
- NomotoSKinoshitaTMoriTAdverse prognosis of epigenetic inactivation in RUNX3 gene at 1p36 in human pancreatic cancerBr J Cancer2008981690169518475302
- KimEJKimYJJeongPHaYSBaeSCKimWJMethylation of the RUNX3 promoter as a potential prognostic marker for bladder tumorJ Urol20081801141114518639281
- ItoKChuangLSItoTLoss of Runx3 is a key event in inducing precancerous state of the stomachGastroenterology20111401536154621277301
- WatanabeTKobunaiTYamamotoYPredicting ulcerative colitis-associated colorectal cancer using reverse-transcription polymerase chain reaction analysisClin Colorectal Cancer20111013414121859567
- YanagawaNTamuraGOizumiHPromoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancersLung Cancer20075813113817606310
- KimTYLeeHJHwangKSMethylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinomaLab Invest20048447948414968123
- SuzukiMShigematsuHShamesDSDNA methylation-associated inactivation of TGFbeta-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancersBr J Cancer2005931029103716234815
- SubramaniamMMChanJYSoongRRUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progressionBreast Cancer Res Treat200911311312118256927
- TyckoBCancer epigenetics and targeted therapiesOncology (Williston Park)20112522823121548465
- YangASDoshiKDChoiSWDNA methylation changes after 5-aza-2′-deoxycytidine therapy in patients with leukemiaCancer Res2006665495550316707479
- KantarjianHOkiYGarcia-ManeroGResults of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemiaBlood2007109525716882708
- MirzaSSharmaGPandyaPRalhanRDemethylating agent 5-aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agentsMol Cell Biochem201034210110920455010
- SandhuRRivenbarkAGColemanWBEnhancement of chemotherapeutic efficacy in hypermethylator breast cancer cells through targeted and pharmacologic inhibition of DNMT3bBreast Cancer Res Treat201213138539921359954
- DaiZJGaoJMaXBUp-regulation of hypoxia inducible factor-1α by cobalt chloride correlates with proliferation and apoptosis in PC-2 cellsJ Exp Clin Cancer Res2012312822453051
- DaiZJGaoJMaXBAntitumor effects of rapamycin in pancreatic cancer cells by inducing apoptosis and autophagyInt J Mol Sci20131427328523344033
- LiQLItoKSakakuraCCausal relationship between the loss of RUNX3 expression and gastric cancerCell200210911312411955451
- ZhongZQSongMMHeYChengSYuanHSKnockdown of Ezrin by RNA interference reverses malignant behavior of human pancreatic cancer cells in vitroAsian Pac J Cancer Prev2012133781378923098471
- ParkSYKwonHJLeeHEPromoter CpG island hypermethylation during breast cancer progressionVirchows Arch2011458738421120523
- LauQCRajaESalto-TellezMRUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancerCancer Res2006666512652016818622
- JiangYTongDLouGZhangYGengJExpression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell linesPathobiology20087524425118580070
- ChenWSalto-TellezMPalanisamyNTargets of genome copy number reduction in primary breast cancers identified by integrative genomicsGenes Chromosomes Cancer20074628830117171680
- KulisMEstellerMDNA methylation and cancerAdv Genet201070275620920744
- SchübelerDEpigenomics: methylation mattersNature200946229629719924205
- IssaJPCancer prevention: epigenetics steps up to the plateCancer Prev Res (Phila)2008121922219138962
- GoreSDJonesCKirkpatrickPDecitabineNat Rev Drug Discov2006589189217117522
- KantarjianHMO’BrienSHuangXSurvival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome: comparison with historical experienceCancer20071091133113717315156
- XuJZhouJYTainskyMAWuGSEvidence that tumor necrosis factor-related apoptosis-inducing ligand induction by 5-Aza-2′- deoxycytidine sensitizes human breast cancer cells to adriamycinCancer Res2007671203121117283156